This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2EV Loftus Jr & WJ Sandborn (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31, 1–20.
4BA Hendrickson , R Gokhale & JH Cho (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15, 79–94.
6R Sullivan , JE Smith & NJ Rowan (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 49, 159–170.
7DL Williams , A Mueller & W Browder (1996) Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin Immunother 5, 392–399.
9DL Williams & IW Browder (1994) Development of natural product (1 → 3)-β-d-glucan polymers as immune-stimulating pharmaceuticals. Polymers Adv Technol 5, 529–534.
10PJ Rice , EL Adams , T Ozment-Skelton , (2005) Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314, 1079–1086.
11I Lavi , D Friesem , S Geresh , (2006) An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett 244, 61–70.
12Y Tao , L Zhang & PC Cheung (2006) Physicochemical properties and antitumor activities of water-soluble native and sulfated hyperbranched mushroom polysaccharides. Carbohydr Res 341, 2261–2269.
15V Vetvicka , BP Thorton & GD Ross (1996) Soluble β glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonised target cells. J Clin Invest 98, 50–61.
17O Ardon , Z Kerem & Y Hadar (1998) Enhancement of lignin degradation and laccase activity in Pleurotus ostreatus by cotton stalk extract. Can J Microbiol 44, 676–680.
18N Kodama , M Yamada & H Nanba (2001) Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol 87, 327–332.
20F Loher , C Bauer , N Landauer , (2004) The interleukin-1β-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T-helper 1 T-cell activation. J Pharmacol Exp Ther 308, 583–590.
22LA Dieleman , MJ Palmen , H Akol , (1998) Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114, 385–391.
24BO Lim , SH Lee , DK Park , (2003) Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci Biotechnol Biochem 67, 1706–1712.
25L Liu , ZP Wang , CT Xu , (2003) Effects of Rheum tanguticum polysaccharide on TNBS-induced colitis and CD4+T cells in rats. World J Gastroenterol 9, 2284–2288.
27HL Chung , GG Yue , KF To , (2007) Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J Gastroenterol 13, 5605–5611.
28A Nusrat , CA Parkos , TW Liang , (1997) Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113, 1489–1500.
29M Nakamura , H Saito , J Kasanuki , (1992) Cytokine production in patients with inflammatory bowel disease. Gut 33, 933–937.
32WE Pullman , S Elsbury , M Kobayashi , (1992) Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102, 529–537.
33Y Raab , Y Raab , B Gerdin , (1993) Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34, 1203–1206.
35A Akazawa , I Sakaida , S Higaki , (2002) Increased expression of tumor necrosis factor α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol 37, 345–353.
36T Olsen , R Goll , G Cui , (2007) Tissue levels of tumor necrosis factor-α correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 42, 1312–1320.
37G Järnerot , E Hertervig , I Friis-Liby , (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128, 1805–1811.
38P Rutgeerts , WJ Sandborn , BG Feagan , (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353, 2462–2476.
39Y Okada , Y Tsuzuki , J Miyazaki , (2006) Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 55, 681–688.
41ME McAlindon , CJ Hawkey & YR Mahida (1998) Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42, 214–219.
43D Rout , S Mondal , I Chakraborty , (2005) Chemical analysis of a new (1 → 3)-, (1 → 6)-branched glucan from an edible mushroom, Pleurotus florida. Carbohydr Res 340, 2533–2539.
44JC Wang , SH Hu , ZC Liang , (2005) Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus in submerged culture and its antitumor effect. Appl Microbiol Biotechnol 67, 759–766.
45S Melgar , MM Yeung , A Bas , (2003) Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 134, 127–137.
46C Asseman , S Mauze , MW Leach , (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995–1003.
49L Wogensen , X Huang & N Sarvetnick (1993) Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J Exp Med 178, 175–185.
50B Balasa & N Sarvetnick (1996) The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 9, 283–286.
51Y Furukawa , G Becker , JL Stinn , (1999) Interleukin-10 (IL-10) augments allograft arterial disease. Paradoxical effects of IL-10 in vivo. Am J Pathol 155, 1929–1939.
53M Neissner & BA Volk (1995) Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RTPCR). Clin Exp Immunol 101, 428–435.
54T Kucharzik , R Stoll & N Lügering (1995) Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 100, 452–456.